
Navigating New Frontiers
The Healthcare Services sector confronts multifaceted challenges amidst rising brick-and-mortar operational expenses and talent shortages. Concurrently, consumer demand for flexible, innovative delivery models offering enhanced service levels and convenience is on the ascent.
Drawing on deep sector expertise, Leerink Partners guides companies through critical industry transformations, and helps them evaluate strategic opportunities to drive growth and maximize value.
Recent Transactions




Our Healthcare Services Team
Our leading team of professionals leverages their knowledge, experience and singular healthcare focus to help our clients achieve their financing and strategic objectives.

Toby King is a Senior Managing Director in Investment Banking at Leerink Partners, focused on the Healthcare Provider continuum. With over 20 years of Healthcare Investment Banking experience, he has advised some of the industry’s leading healthcare providers and private equity firms across a wide variety of situations.
Toby joined Leerink Partners in 2021 from Citigroup, where he spent more than a decade, most recently as Managing Director and Head of North America Healthcare leading efforts with individual coverage across hospitals, alternate-site providers, behavioral health, outsourcing and post-acute care. Prior to Citigroup, he spent over ten years in the Healthcare Group at Merrill Lynch. Prior to investment banking, he worked at HCA’s Corporate Finance and Development group.
He holds a B.A. from Bellarmine University and an M.B.A. from The University of Chicago, Booth School of Business.

Philip Boyd is a Senior Managing Director in Investment Banking at Leerink Partners, he will help lead M&A efforts across Healthcare Services and Technology as well as support clients in the Healthcare Services Providers space. Phil has advised a wide variety of clients on mergers and acquisitions, divestitures, spin-offs, recapitalizations, leveraged buyouts, takeover defense, and capital raising.
Phil joined the Firm in 2024 from Guggenheim Securities, where he spent nearly a decade in the healthcare services sector, leading efforts to execute strategic transactions involving both public and private companies. Earlier in his career, he was an associate in Citigroup’s Healthcare Investment Banking Group.
He earned his B.S. in Applied Economics and Management and his M.B.A. from Cornell University.

Ben Brown is a Senior Managing Director in Investment Banking at Leerink Partners and leads the Firm’s Pharma Services practice. With over 20 years of Investment Banking and investing experience, he has executed M&A and equity transactions for clients across several verticals, including pharma outsourcing and IT, payor and provider services, healthtech, software, consulting and human capital services.
Ben joined Leerink Partners in 2021 from Baird, where he spent over 15 years, most recently as Managing Director and Head of Global Pharma Services Investment Banking. Prior to Baird, he held Investment Banking and private equity positions with Thomas Weisel Partners, The Halifax Group, Growth Capital Partners and Prudential Capital Group.
He holds a B.B.A. from Southern Methodist University (cum laude) and an M.B.A. from Northwestern University, Kellogg School of Management.

Michael Clifford is a Senior Managing Director in Investment Banking at Leerink Partners covering Healthcare Technology and Services and supporting the Firm’s Mergers & Acquisitions efforts.
With more than 13 years of Healthcare Investment Banking experience, he has led efforts to execute strategic transactions for a variety of public and private companies on mergers & acquisitions, equity offerings (IPOs, follow-ons and private placements), acquisition financings and debt financings. Michael joined the Firm in 2015 from Wells Fargo Securities where he worked in the Consumer and Healthcare Investment Banking Group covering Healthcare Technology and Services verticals. Prior to Wells Fargo Securities, he worked in the Transaction Services group at PwC in New York.
He holds a BSBA (cum laude) in Financial Management & Investments and Accounting from the University of Arkansas.

Robert Jackey is a Senior Managing Director in Investment Banking at Leerink Partners and is focused on coverage for Physician Services and Healthcare Provider companies. With over 18 years of Healthcare Investment Banking experience, he has led efforts to execute strategic transactions for a variety of public and private companies. Bob’s advisory and execution experience spans the spectrum of traditional provider organizations through high-growth healthcare disruptors, including domestic and multinational corporations.
Robert joined Leerink Partners in 2021 from Citigroup, where he spent over 16 years, most recently as Managing Director, covering the alternate site / sub-acute, behavioral, clinical staffing / outsourcing, dental, hospital / acute care, patient transportation, physician organization and veterinary verticals.
He holds a B.S. (summa cum laude) in electrical engineering as well as an M.B.A. from Fairleigh Dickinson University.

Robert Minear is a Senior Managing Director of Investment Banking focused on leading the Firm’s financial sponsor origination efforts to further enhance the Firm’s growing private equity and leveraged finance businesses. With over 20 years of investment banking experience, Robert has advised a wide variety of domestic and international financial sponsor and strategic clients in connection with, inter alia, mergers and acquisitions, divestitures, spin-offs/split-offs, restructurings, recapitalizations, buyouts, takeover defense, proxy contests and capital raisings.
Robert joined the Firm in 2021 from Guggenheim Securities where he was a Senior Managing Director in the Healthcare Services Investment Banking Group focusing on advising companies and financial sponsors in the healthcare services sector. Prior to that, he was a Managing Director and Head of Healthcare Services Mergers and Acquisitions in Jefferies Group’s Healthcare Investment Banking practice and a member of the M&A groups at UBS, both in New York and London, and Deutsche Bank.
He received his Master’s degree in Aeronautical Engineering from Imperial College, University of London.